CARDIOVASCULAR DISEASES
The Leading Cause of Death Worldwide
Cardiovascular disease (CVD) is the leading cause of death globally, accounting for 25% of deaths in the U.S. and 31% of deaths worldwide. Nearly 18 million people die each year from cardiovascular disease (CVD)-related events including myocardial infarction (MI).
Despite current standard of care treatments, residual risk of MI, stroke and death remains high in patients with CVD. Developing new treatments is a challenge due to the heterogeneity of the patient population and the resulting variation in response to treatment.
Scientific advances in precision medicine now allow for a patient’s genetic profile to be considered during the development of new treatments. This targeted approach identifies individual patients who may benefit from a particular treatment, based on a specific genetic subtype.
DalCor is developing dalcetrapib, the first precision medicine aiming to reduce fatal and non-fatal MI above and beyond the current standard of care in patients who carry the ADCY9 rs1967309 AA genotype.
Despite current standard of care treatments, residual risk of MI, stroke and death remains high in patients with CVD. Developing new treatments is a challenge due to the heterogeneity of the patient population and the resulting variation in response to treatment.
Scientific advances in precision medicine now allow for a patient’s genetic profile to be considered during the development of new treatments. This targeted approach identifies individual patients who may benefit from a particular treatment, based on a specific genetic subtype.
DalCor is developing dalcetrapib, the first precision medicine aiming to reduce fatal and non-fatal MI above and beyond the current standard of care in patients who carry the ADCY9 rs1967309 AA genotype.
Canada
SWITZERLAND
UNITED KINGDOM
UNITED STATES